Drug Targeting to Immune Cells Using Modified Inulin Particles

Vaxine Pty Ltd是一家澳大利亚生物技术公司，该公司发现了可被人体免疫细胞有效内化的特定颗粒形式的菊粉。该项目旨在利用细胞迁移到损伤和感染部位，通过将药物附着到菊糖颗粒上来创建靶向药物递送系统。该系统将专门将药物运送到受影响地区，降低药物的全身浓度，从而降低与剂量相关的副作用的风险。该项目具有改善医疗保健和鼓励澳大利亚生物技术行业专业知识增长的潜力。

Vaxine Pty Ltd is an Australian biotechnology company that has discovered specific particulate forms of inulin that are efficiently internalised by human immune cells. This project aims to exploit cell migration to injury and infection sites by attaching drugs to inulin particles creating a targeted drug delivery system. This system will transport drugs specifically to afflicted areas, reducing systemic concentrations of drugs and hence the risks of dose related side effects. This project has potential both to improve healthcare and to encourage the growth of expertise in the biotechnology industry in Australia.